peptide · regulated markets
Peptide Creator Retainer vs One-Off, When the Cadence Pays
On this page
A founder asked me last Tuesday to book one peptide creator for one post. A peptide is a short chain of amino acids; some are sold as recovery or performance compounds. The brand wanted a single insertion with VigorousClips, a 13K-subscriber clips channel covering performance enhancement. My answer was no.
VigorousClips posted 27 Marek Health reads in 25 days. Marek Health is a US testosterone and peptide telehealth clinic. That cadence is one ad per day for almost a month. Any rival peptide brand pitching the same creator in that window hits a conflict block at contract stage.
Across 242 Marek Health deals across 32 creators since January 2024 in our log, the working third of the roster carries the bulk of the volume. The pattern is closer to a weekly read than a monthly one.
The cadence question most peptide brands skip
The bottleneck most peptide brands hit is not creator supply. It is the per-post fixed cost of regulated-category review.
Legal review, claim-language audit, FTC disclosure check, and platform-rule sign-off run flat per post. A one-off eats the full overhead on a single read. A quarterly retainer spreads the same cost over six to ten reads.
The math collapses to cost per signup. A one-off pays the compliance bill once and gets one shot. A retainer pays the same bill once and gets four to ten shots. The retainer wins unless every later post drops 75 percent or more. In a category where audience familiarity drives signup intent, that drop is rare.
Most peptide brands skip the math and default to per-post pricing because the contract is shorter. The per-signup cost lands two to three times higher than the retainer math predicts, here is the cost-per-signup read we send peptide brands before any first email goes out.
What the Marek Health pattern actually looks like
Marek Health is the most-retainer-like cadence we track in peptide. The 242 deals across 32 creators average roughly 7 to 8 paid posts per creator. The distribution is heavily skewed.
VigorousClips posted 27 Marek reads in 25 days. Mark Bell's Power Project, a 384K-subscriber strength-training podcast, posted 20 in 124 days. SAMSON DAUDA, an IFBB pro bodybuilder, posted 17 across 359 days. Joshua Settlage at 43.2K subscribers posted 15 in 87 days. The top five carry most of the volume. Marek is buying repeat reads from a small bench of audience-pre-qualified creators.
Wondering if your shortlist looks like Marek's? The deal log we run on every peptide brief shows you which target creators already sit in a no-rival window with another peptide brand, before any outreach lands. Free for any peptide brief with a clear launch quarter.
Send us a peptide brief and we'll run the cadence read →Audience trust on a regulated treatment compounds across reads. Post one is the audience hearing the brand for the first time. Post three is the audience remembering the URL. Post six is the audience signing up because two friends already did. A one-off brand never gets past post one.
One verbatim CTA from the Mark Bell pattern reads:
marekhealth.com and use code "POWERPROJECT" for 10% off Self-Service Labs and Guided Optimization®
Mark Bell's Power Project, March 2026 paid read
The code is creator-specific. The URL is brand-stable. The cadence is the lever.
Four cadence archetypes from one-off to always-on
Four archetypes show up in the deal log. Each fits a different brand stage.
Level 1 is the one-off insertion. A single post, no follow-up, often used for launch awareness. Cost per signup runs high. The compliance overhead eats the margin on the single read.
Level 2 is the monthly read. One post per month on a rolling 90-day commitment. SAMSON DAUDA posted 17 Marek reads over 359 days, roughly one paid read every 21 days.
Level 3 is the quarterly retainer. Three to four posts in a single quarter on a renewable contract. Joshua Settlage at 15 Marek deals over 87 days fits, roughly one read every 6 days. This is where compliance amortization kicks in.
Level 4 is the always-on slot. The creator runs the brand weekly or biweekly across a 6 to 12 month window. VigorousClips at 27 reads in 25 days is the extreme. Mark Bell at 20 reads over 124 days is the realistic upper band.
The archetype a brand picks is a function of how many creators have already passed vetting, not budget. A brand with one vetted creator and a $40,000 quarterly budget should run that creator at Level 3. Spreading the same budget across four un-vetted creators at Level 1 pays the vetting cost four times and the audience-trust compounding zero times.
- Compliance overhead burned on one post instead of spread across six
- No-rival windows on the best creators already locked by Marek Health
- Per-signup cost two to three times higher than the retainer math predicts
Across 242 Marek Health deals on 32 creators in our sponsor log, the top five carry most of the volume on a weekly-to-monthly cadence. A competing brand pitching them for a one-off hits the conflict rejection every time.— Internal sponsor-deal log, Jan 2024 to Apr 2026Build a peptide retainer roster, free read →
What a retainer buys that a one-off never can
The retainer buys two things a one-off cannot price. Audience-trust compounding, and category lock.
Would a rival peptide brand pitch a creator who runs Marek Health every six weeks? In our log, the answer is no. Asking a creator to run two competing peptide brands at the same cadence destroys the trust signal that made the first deal work. The retainer is an exclusivity moat priced slightly above one-off market rate.
The same 32 creators Marek works with are each the natural first call for any new peptide brand. A brand entering today either negotiates a buy-out, or finds an adjacent creator the incumbents have not locked, here is the no-rival-window check we run before any peptide outreach lands.
The second-order benefit nobody puts on the rate card is the legal-hours drop. A first read needs the full briefing pack: claim audit, FTC disclosure brief, platform medical-claim rules, script review. A sixth-time read needs a two-page brief. The FDA has been pushing tighter rules on compounded peptides for the past 18 months (see the September 2025 sweep of 30 warning letters to compounded GLP-1 marketers). Compliance cost is going up. The retainer is how a brand keeps unit economics from cratering.
When a one-off peptide deal still wins
One-off still wins under three specific conditions.
The first is a launch-window push needing reach across many audiences inside 30 days. Spreading budget thin beats concentrating it on a few.
The second is a seasonal attention moment. A New-Year GLP-1 push, where GLP-1 means glucagon-like peptide-1, the weight-loss drug class like Ozempic and Mounjaro. Lorraine Kamesha at 59.2K subscribers posted 22 Orderly Meds reads in 28 days during the January 2026 window. Orderly Meds is a GLP-1 telehealth brand. The spike will not repeat for 11 months.
The third is a creator with past-deal drift. A fitness creator who has run one peptide brand but mostly runs supplement deals. Signing a retainer would inherit risk the brand did not sign up for.
Outside those three, the one-off is the lazy default. A brand defaulting to one-off because the contract is shorter pays the full compliance overhead on a single post and walks away from the trust compounding that makes the next post cheaper.
Where We Come In
The downside on a peptide one-off is bounded. The upside is also bounded, because the audience-trust compounding never starts. The downside on a retainer is bounded the same way: vet wrong, lose a quarter. The upside compounds across every renewal.
We build the retainer roster for you. The past-deal history, cadence pattern, and category-lock status for every peptide creator worth booking already lives in our database, here is the quarterly cadence read we send before your next launch window opens.
Cadence is the lever.
FAQ
Should I pay a peptide creator quarterly or per post?
Default to a quarterly retainer for any creator who passes peptide-brand review. The per-post compliance cost gets paid down across more posts. The category-lock window blocks a rival from buying the same audience next month. Per-post only fits a launch push, a seasonal moment, or a creator with past-deal drift.
What cadence do top peptide brands actually run?
Marek Health runs 242 deals across 32 creators. VigorousClips posted 27 reads in 25 days. Mark Bell's Power Project posted 20 in 124 days. That reads as a weekly-to-monthly cadence on the working third of the roster.
When does a one-off peptide deal still make sense?
A launch push needing reach inside 30 days. A seasonal moment like the January GLP-1 window. A creator with past-deal drift that would make a retainer inherit risk you did not sign up for.
Reading loop
Frequently asked
Should I pay a peptide creator quarterly or per post?
Default to a quarterly or always-on retainer for any creator who passes peptide-brand review. The per-post compliance cost gets paid down across more posts. The category-lock window blocks a rival peptide brand from buying the same audience next month. Per-post pricing only fits a launch push, a single seasonal moment, or a creator with past-deal drift.
What cadence do top peptide brands actually run?
Marek Health, a US testosterone and peptide telehealth clinic, runs 242 deals across 32 creators in our database. VigorousClips posted 27 Marek reads in 25 days. Mark Bell's Power Project posted 20 in 124 days. That reads as a weekly-to-monthly cadence on the working third of the roster, not one-off insertions.
When does a one-off peptide deal still make sense?
One-off wins for a launch push needing reach across many audiences in 30 days. It wins for a seasonal moment like a New-Year GLP-1 push, where GLP-1 means glucagon-like peptide-1, the weight-loss drug class like Ozempic. It also wins for a creator with past-deal drift that would make a retainer inherit risk.